Filter posts

Judd Gregg: Biodefense Funding Is Crucial to National Security

Writing in the Morning Consult, former Senator Judd Gregg explains critical role of federal programs …

The Hill: Will Support for Biomedical Research Be Dead on Arrival?

In an op-ed over at The Hill, Dr. Claire Pomeroy, an infectious disease specialist and …

Jim Greenwood Op-Ed: Time to Fund Medical Countermeasures against Threats like Ebola

On Friday, The Hill published an op-ed from BIO President and CEO Jim Greenwood calling …

U-T San Diego Commentary: Lack of Preparedness to Ebola Is Symptom of Larger Disease

Last week, the U-T San Diego published an op-ed by Betrand Liang, CEO of Pfenex …

Delivering on Biotech’s Promise to Treat Anthrax, Smallpox, Ebola

Thanks to federal biodefense programs that partner with industry to develop and stockpile medical countermeasures, …

BIO Calls for Adequate Funding of Vaccine and Biodefense Programs

It’s budget time here in Washington, with appropriators in the House and Senate working overtime …

Renewing the Project BioShield Act: What Has It Bought and Wrought?

In the next several months, the U.S. Government will decide whether to continue the funding …